Stay updated on Safety and Efficacy of Aflibercept in AMD Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy of Aflibercept in AMD Clinical Trial page.

Latest updates to the Safety and Efficacy of Aflibercept in AMD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check21 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check30 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about the HHS Vulnerability Disclosure.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
- Check51 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference1%
Stay in the know with updates to Safety and Efficacy of Aflibercept in AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of Aflibercept in AMD Clinical Trial page.